Literature DB >> 12630607

The Magenstrasse and Mill operation for morbid obesity.

David Johnston1, Jenny Dachtler, Henry M Sue-Ling, Roderick F G J King, lain G Martin.   

Abstract

BACKGROUND: Our aim was to evolve a simpler, more physiological type of gastroplasty that would dispense with implanted foreign material such as bands and reservoirs. The Magenstrasse, or "street of the stomach", is a long narrow tube fashioned from the lesser curvature, which conveys food from the esophagus to the antral Mill. Normal antral grinding of solid food and antro-pyloro-duodenal regulation of gastric emptying and secretion are preserved.
METHODS: 100 patients with morbid obesity (83M, 17F, mean age 40 years) were treated by the Magenstrasse and Mill procedure and followed-up for 1-5 years. Mean preoperative BMI was 46.3 kg/m2, and mean excess weight was 106%.
RESULTS: Operative mortality was 0. Major complications occurred in 4% of patients. There were few side-effects, although mild heartburn was fairly common. Mean weight loss was 38 kg (+/- 14 kg), equivalent to 60% of excess weight, achieved within 1 year of operation, after which no further significant gain or loss of weight occurred.
CONCLUSIONS: The Magenstrasse and Mill procedure is the simplest and most physiological gastroplasty yet described. Many of the drawbacks of vertical banded gastroplasty, adjustable banding and gastric bypass are avoided. It is safe, has few side-effects and leads to major and durable weight losses, similar to those produced by other types of gastroplasty.

Entities:  

Mesh:

Year:  2003        PMID: 12630607     DOI: 10.1381/096089203321136520

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  42 in total

1.  Antireflux sleeve gastroplasty: description of a novel technique.

Authors:  Vadim Fedenko; Vladimir Evdoshenko
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

2.  The First International Consensus Summit for Sleeve Gastrectomy (SG), New York City, October 25-27, 2007.

Authors:  Mervyn Deitel; Ross D Crosby; Michel Gagner
Journal:  Obes Surg       Date:  2008-05       Impact factor: 4.129

Review 3.  Revisional bariatric surgery for inadequate weight loss.

Authors:  Andrew A Gumbs; Alfons Pomp; Michel Gagner
Journal:  Obes Surg       Date:  2007-09       Impact factor: 4.129

4.  Our 1-year experience in laparoscopic sleeve gastrectomy.

Authors:  Ganesh Ramalingam; Cheng Kui Seng Anton
Journal:  Obes Surg       Date:  2011-12       Impact factor: 4.129

5.  Laparoscopic sleeve gastrectomy for the super-super-obese (body mass index >60 kg/m(2)).

Authors:  Michel Gagner; Andrew A Gumbs; Luca Milone; Elliot Yung; Liz Goldenberg; Alfons Pomp
Journal:  Surg Today       Date:  2008-04-30       Impact factor: 2.549

6.  Early Weight Recidivism Following Laparoscopic Sleeve Gastrectomy: A Prospective Observational Study.

Authors:  Mohamed H A Fahmy; Mohamed D Sarhan; Ayman M A Osman; Ahmad Badran; Amr Ayad; Dalia K Serour; Hany A Balamoun; Mohamed E Salim
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

Review 7.  A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, Roux-en-Y gastric bypass and adjustable gastric banding.

Authors:  Juan Victor A Franco; Pablo Adrian Ruiz; Mariano Palermo; Michel Gagner
Journal:  Obes Surg       Date:  2011-09       Impact factor: 4.129

8.  The influence of laparoscopic sleeve gastrectomy on metabolic syndrome parameters in obese patients in own material.

Authors:  Hady Razak Hady; Jacek Dadan; Magdalena Luba
Journal:  Obes Surg       Date:  2012-01       Impact factor: 4.129

Review 9.  Sleeve gastrectomy and anti-reflux procedures.

Authors:  Christopher Crawford; Kyle Gibbens; Daniel Lomelin; Crystal Krause; Anton Simorov; Dmitry Oleynikov
Journal:  Surg Endosc       Date:  2016-07-20       Impact factor: 4.584

10.  The Super-Magenstrasse and Mill operation with pyloroplasty: preliminary results.

Authors:  C Vassallo; G Berbiglia; A Pessina; M Carena; A Firullo; A Griziotti; F Ramajoli; E Palamarciuc; M Fariseo
Journal:  Obes Surg       Date:  2007-08       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.